Thyrocare Technologies Limited

NSEI:THYROCARE Stock Report

Market Cap: ₹34.1b

Thyrocare Technologies Dividend

Dividend criteria checks 2/6

Thyrocare Technologies is a dividend paying company with a current yield of 2.8%.

Key information

2.8%

Dividend yield

0%

Payout ratio

Industry average yield0.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₹12.36
Dividend yield forecast in 3Y2.0%

Recent dividend updates

Recent updates

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?

Oct 28
How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?

Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares

Oct 07
Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares

The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More

Sep 29
The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More

Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?

Sep 11
Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?

Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares

Aug 22
Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares

Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings

Aug 17
Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Jul 30
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking

Jul 28
Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking

Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jul 04
Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: THYROCARE has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: THYROCARE's dividend payments have increased, but the company has only paid a dividend for 8 years.


Dividend Yield vs Market

Thyrocare Technologies Dividend Yield vs Market
How does THYROCARE dividend yield compare to the market?
SegmentDividend Yield
Company (THYROCARE)2.8%
Market Bottom 25% (IN)0.3%
Market Top 25% (IN)1.2%
Industry Average (Healthcare)0.3%
Analyst forecast in 3 Years (THYROCARE)2.0%

Notable Dividend: THYROCARE's dividend (2.8%) is higher than the bottom 25% of dividend payers in the Indian market (0.26%).

High Dividend: THYROCARE's dividend (2.8%) is in the top 25% of dividend payers in the Indian market (1.18%)


Earnings Payout to Shareholders

Earnings Coverage: Unable to calculate sustainability of dividends as THYROCARE has not reported any payouts.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (147.3%), THYROCARE's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.